Making use of an individual’s genetic signature, Sirius Genomics is developing rapid, DNA-based diagnostic and pharmacogenetic tests for critical care illnesses. Our expert medical and scientific team uses a proprietary database to correlate patient genetics with clinical outcomes, leading to proprietary and commercially-viable products for intensive care medicine. With these tests, Sirius Genomics expects to make personalized medicine a reality for critically ill patients.